Mutational drivers of thyroid cancer
24 Nov 2016
Mutational drivers of thyroid cancer
Towards delivering truly personalised therapy for oesophageal cancer
PDL-1 assay concordance
ESMO 2016 conference highlights
Results of the Activ8 trial of novel immunotherapy motolimod
Highlights of ESMO 2016
Clinical trials investigating proton therapy for other indications
Summary of developments in oesophageal and gastric cancers
ß1 integrins and DNA repair for radiosensitization of head and neck cancer
'Rewiring' tumour susceptibility
A global perspective on infections related to cancer
Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC